MOTS-C is a mitochondrial-derived peptide (MDP) naturally encoded within mitochondrial DNA and recognised for its role in regulating cellular metabolism, energy production, and metabolic health. Unlike traditional peptides that primarily target hormones or growth factors, MOTS-C works directly at the cellular level to improve mitochondrial function, enhance insulin sensitivity, and promote efficient fat metabolism. Its unique ability to activate metabolic pathways involved in energy utilisation has made MOTS-C an emerging peptide of interest for body composition, athletic performance, recovery, and healthy aging. MOTS-C activates AMP-activated protein kinase (AMPK), one of the body's primary metabolic regulators responsible for maintaining cellular energy balance. Activation of AMPK enhances glucose uptake into skeletal muscle, improves insulin sensitivity, promotes fatty acid oxidation, and encourages the body to utilise stored fat as an energy source. By supporting mitochondrial efficiency and reducing metabolic stress, MOTS-C helps improve endurance, exercise capacity, metabolic flexibility, and overall energy production while supporting lean body composition. MOTS-C is commonly incorporated into research and wellness protocols for: Dosage should be individualized according to treatment goals and administered under the supervision of a qualified healthcare professional. Store lyophilized vials at 2–8°C, protected from direct sunlight. After reconstitution, refrigerate immediately, avoid freezing, and maintain proper aseptic handling during preparation and administration. MOTS-C is generally well tolerated in available research. Mild injection-site discomfort, redness, headache, temporary fatigue, nausea, or changes in appetite may occasionally occur. Individuals with diabetes or those using glucose-lowering medications should monitor blood glucose appropriately. If severe or persistent adverse effects occur, discontinue use and consult a healthcare professional. MOTS-C should only be used under professional medical supervision. Individuals with diabetes, metabolic disorders, liver or kidney disease, or those who are pregnant or breastfeeding should consult a healthcare provider before use. Regular monitoring of blood glucose and metabolic health may be recommended during treatment. Long-term human clinical data remain limited. MOTS-C is commonly incorporated into fat-loss and metabolic optimisation protocols. It may be used alongside GLP-1 receptor agonists, growth hormone secretagogues, recovery peptides, or performance-support compounds under appropriate professional supervision. Combination protocols should be individualized according to body composition, metabolic health, and performance goals. The information provided is for educational purposes only and is not intended as medical advice. Use MOTS-C only under professional supervision. Product images are for illustration purposes only and may differ from the actual product. Packaging and labeling are subject to change without prior notice.MOTS-C
MOTS-C – 15 mg
How It Works
Frequently Used For
Dosage & Storage
Possible Side Effects
Precautions
Stacking Compatibility
Disclaimer